论文部分内容阅读
慢性乙型肝炎是由乙型肝炎病毒（ＨＢＶ）感染而导致的一种难治性肝脏疾病，至今尚无特效治疗方法。以国际学术界公认抗ＨＢＶ有效的α—干扰素来说，其治疗慢性乙肝炎的持久应答率仅在３０％左右，且在有效剂量下存在诸多不良反应。为了探讨治疗慢性乙型肝炎的中医有效方...
Chronic hepatitis B is a refractory liver disease caused by Hepatitis B virus (HBV) infection, so far there is no effective treatment. To the international academic community recognized anti-HBV effective α-interferon, its long-term response rate of chronic hepatitis B treatment is only about 30%, and there are many adverse reactions at effective doses. In order to explore the effective treatment of chronic hepatitis B Chinese medicine ...